Cellectar biosciences, inc. (CLRB)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-14,428

-14,092

-14,540

-13,651

-13,384

-13,239

-13,490

-13,945

-14,146

-13,562

-12,068

-10,884

-9,896

-6,180

-2,644

-2,215

-2,369

-5,495

-9,792

-7,610

-7,409

-8,052

-8,653

-10,293

-10,271

-10,782

-8,990

-9,727

-9,893

-8,796

0

0

0

Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization

134

132

132

114

97

82

1,301

1,391

1,476

1,546

381

363

352

356

360

363

363

362

361

359

361

367

376

393

408

424

438

451

469

497

0

0

0

Stock-based compensation expense

803

866

867

881

755

721

698

711

766

758

705

703

591

529

415

406

358

447

596

577

779

850

1,904

2,055

2,159

2,323

1,444

1,483

1,511

1,503

0

0

0

Non cash lease Expense

58

56

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense related to convertible debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

426

0

0

0

-

-

-

-

-

-

-

-

Intrinsic value of beneficial conversion feature associated with convertible debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Non-cash interest expense related to convertible debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Issuance of stock for technology and services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Impairment of intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Loss on disposal of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

-0

-0

-0

-2

-5

-5

-5

-7

-4

-4

-4

0

0

0

0

Loss on revaluation of derivative warrants

47

43

86

106

85

62

24

-32

77

22

77

245

354

3,261

6,342

6,398

6,204

3,667

-557

2,058

2,628

2,285

3,479

2,226

2,312

2,373

0

0

0

-

-

-

-

(Gain) loss on revaluation of derivative warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Loss on issuance of derivative warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-744

-744

-744

-744

0

0

0

0

Changes in:
Prepaid expenses and other current assets

166

129

286

1,112

300

229

-167

-735

-588

-281

416

794

719

464

121

43

2

8

25

-43

-41

-74

-54

-0

5

-48

-6

8

8

72

0

0

0

Other assets

0

-

-

-576

19

81

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liability

-618

-81

-57

-33

511

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued liabilities

1,408

1,120

368

499

-285

-258

552

627

697

451

931

649

577

740

507

104

-215

-258

-559

-483

-168

-228

-17

173

129

445

444

413

391

238

0

0

0

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

11

0

0

0

Other assets and liabilities

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

Cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-7,379

-7,664

-8,212

-8,859

-8,791

-8,612

-8,840

-9,377

-9,834

-9,860

-9,154

0

0

0

-

-

-

-

Cash used in operating activities

-12,390

-11,693

-11,756

-11,180

-11,073

-11,442

-11,524

-11,098

-11,216

-11,020

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

CASH FLOWS FROM INVESTING ACTIVITIES:
Cash acquired in a business combination

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Purchases of fixed assets

28

24

402

399

389

384

1

27

281

346

413

388

138

72

23

29

33

58

51

48

39

29

30

70

70

147

195

161

175

97

0

0

0

Proceeds from sale of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Purchases of short-term certificates of deposit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Proceeds from short-term certificates of deposit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Change in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,000

0

1,878

1,878

2,000

0

0

0

Payment for intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-29

-33

-58

-51

-48

-39

-29

-30

1,808

1,808

1,852

0

0

0

-

-

-

-

Cash used in investing activities

-28

-24

-392

-344

-334

-329

43

-27

-281

-346

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

CASH FLOWS FROM FINANCING ACTIVITIES:
Payments on capital lease obligations.

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

326

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of warrants

-

-

-

-

-

-

-

-

-

-

-

-

3,587

652

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Reverse stock split fractional shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,000

4,000

4,000

4,000

0

0

0

0

0

0

0

0

Payments on notes payable

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock, net of underwriting issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,975

6,942

6,942

11,813

6,838

0

0

0

Payments on capital lease obligations

-

-

-

-

-

-

-

2

2

2

2

2

2

2

2

2

2

2

2

2

2

1

2

2

2

2

2

2

2

2

0

0

0

Proceeds from conversion of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,088

1,088

0

0

0

Proceeds from long-term obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Payments on long-term obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

119

0

0

0

-

-

-

-

-

-

-

0

0

0

0

0

Repurchase of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Cash in lieu of fractional shares in a business combination

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Change in deferred issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

70

0

0

0

-70

0

0

0

Cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,497

2,576

2,706

-191

12,047

11,873

15,874

15,873

3,823

3,997

5,043

0

0

0

-

-

-

-

Cash (used in) provided by financing activities

9,023

9,022

9,021

24,138

15,021

15,021

22,192

6,994

7,080

9,928

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

NET DECREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH

-3,396

-2,695

-3,126

12,613

3,613

3,249

10,711

-4,132

-4,418

-1,438

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH

-

-

-

-

-

-

-

-

-

-

-

-

-

7,586

3,173

3,088

-5,121

-5,564

-9,103

3,207

3,221

7,004

6,465

-4,202

-4,054

-2,259

-487

-1,318

4,074

-828

0

0

0

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for interest expense

1

0

1

0

0

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Obtaining a right-of-use asset in exchange for a lease liability

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liability established through right-of-use asset

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fair value of derivative warrants issued

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,720

5,720

5,720

5,720

0

0

0

0

Relative fair value of warrants issued with debentures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

254

254

254

254

0

0

0

0

-

-

-

-

Cash paid for interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

25

47

45

0

0

0

-

-

-

-

-

-

-

0

0

0

0

0

Fair value of derivative warrants reclassified to equity upon cashless exercise

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

24

43

0

0

0

Issuance of common stock in connection with the conversion of notes payable and $463,722 in accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Fair value of assets acquired in exchange for securities in a business combination

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Reclassification to equity for warrants that are no longer derivative instruments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Goodwill resulting from business combination

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0